recent article produced for IiME by Dr Jo Cambridge  the status of the
current work being undertaken by the team was described.
The aim of this initial
study at UCL is to establish baseline parameters in anticipation of
monitoring the numbers, sub-types and functions of B-cells (a sub-population
of white blood cells) during the anticipated clinical trial of rituximab
which IiME will be funding.
discussions at the first Invest in ME (Research) Advisory Board meeting last month we
discussed with Dr Cambridge the need to extend the work being performed on
B-cells with regard to ME research.
in ME are therefore committing ourselves to fund a new PhD studentship at
UCL beginning next year.
exciting news will secure the longer term research into ME and augment the proposed rituximab clinical trial.
this as a critical development to which we need to commit at an early stage
in order to avoid losing momentum in the future. We have been impressed by
Dr Cambridge's pro-active approach and the UCL team's can-do attitude which
resonates with the charity's ethos.
our Advisory Board meeting we have heard of promising news.
supporters and the impressive Let's Do It For ME collaboration have shown
what the future could hold for ME patients and their families and firmly
underpins the charity's total commitment to biomedical research into ME.
also reinforces our plans for a Centre of Excellence proposal.
ME is now forging a strategy of biomedical research which has been lacking
in the UK.
Together with wonderful supporters and our European ME Alliance partners we
are forcing change to occur in the establishment.
like to thank our supporters for their efforts, their support, their
encouragement and their loyalty
Make a one-off donation via credit card or Paypal
Other Ways to Donate -
to IiME UK rituximab trial News page